Roche announces positive results of pivotal Phase III study with pertuzumab in HER2-positive metastatic breast cancer
8 December 2011 | By Roche
6.1 month improvement in median progression free survival, from 12.4 to 18.5 months...
List view / Grid view
News
Janssen Biotech, Inc. announces collaborative development and worldwide license agreement for investigational anti-cancer drug, PCI-32765
8 December 2011 | By Johnson & Johnson
Compound in development for multiple B-cell hematologic malignancies...
New data confirms Novartis drug Afinitor® significantly extends time women with advanced breast cancer live without tumor growth
8 December 2011 | By Novartis
Updated results of a Phase III study...
Syrris releases new batch chemistry reactors catalogue
7 December 2011 | By kdm communications limited
Syrris is pleased to announce the release of its new batch chemistry reactors catalogue...
Tecan launches Infinite® M1000 PRO with AlphaScreen® and AlphaLISA® technology
6 December 2011 | By kdm communications limited
Infinite M1000 PRO is Tecan’s latest generation high-end multimode microplate reader...
Merck Millipore launches ChromaTALK™
6 December 2011 | By Merck Millipore
Experts from around the world share perspectives and insights on topics related to process-scale chromatography...
Fewer major adverse cardiovascular events in type 2 diabetes patients treated with JANUVIA ® (sitagliptin)
6 December 2011 | By MSD
Data presented at the IDF 21st World Diabetes Congress...
Combination insulin degludec/insulin aspart significantly reduced hypoglycaemia in diabetes patients
6 December 2011 | By Novo Nordisk
Insulin degludec / insulin aspart reduced rates of hypoglycaemia by 58%...
Merck establishes new MSD R&D Asia Headquarters
6 December 2011 | By
Commits $1.5 billion to R&D in China over the next 5 years...
Sanofi reports positive results for once-daily Lyxumia® (lixisenatide) in Combination with Lantus® (insulin glargine) in Type 2 Diabetes
6 December 2011 | By Sanofi
Data from phase III GetGoal Duo 1 study...
Government boost to world leading UK life science industry
5 December 2011 | By http://www.bis.gov.uk/newsroom
Three million at-risk patients to receive hi-tech equipment in the home - part of a series of measures outlined by the Prime Minister today to support the UK’s life sciences industry...
GSK statement in response to the Prime Minister’s speech on life sciences
5 December 2011 | By GlaxoSmithKline
"The Government’s strategy for Life Sciences is a very important next step on the journey..."
Samsung and Biogen Idec announce joint venture to develop, manufacture and market biosimilars
5 December 2011 | By Biogen Idec
Samsung and Biogen Idec announced that they have entered into an agreement to invest $300 million to establish a joint venture to develop, manufacture and market biosimilars...
Study in type 2 diabetes shows low rates of hypoglycaemia and significant improvements in blood glucose control with insulin analogue treatment
5 December 2011 | By Novo Nordisk
New data from the A1chieve® study...
Groundbreaking scientific collaboration gives UK academia access to compounds to advance medical research
5 December 2011 | By AstraZeneca
A wide range of compounds will be made available FOC to UK medical researchers...
